Latest filing published 20 Oct 2020 for RAPT Therapeutics, Inc..
Insider track record
No signal scores available.
Kleiner Perkins Caufield & Byers XV, LLC: trading record in brief
Kleiner Perkins Caufield & Byers XV, LLC discloses dealings in 2 companies, chiefly RAPT Therapeutics, Inc. and Atara Biotherapeutics, Inc. We count 13 filings; the first trade dates from 21 October 2014 and the latest from 16 October 2020.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The latest filing, published on 20 October 2020, reports a transaction in RAPT Therapeutics, Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Kleiner Perkins Caufield & Byers XV, LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 650,000 shares0Common StockSEC:0001104659-20-116400:0
- 650,000 shares0Common StockSEC:0001104659-20-104516:0
- 300,000 shares0Common StockSEC:0001104659-20-084103:0
- 363,504 sharesCommon StockSEC:0001209191-19-055030:2
- 145,401 sharesCommon StockSEC:0001209191-19-055030:3
- 2,871,492 sharesCommon StockSEC:0001209191-19-055030:0
- 166,666 sharesCommon StockSEC:0001209191-19-055030:1
- 291,300 shares0Common StockSEC:0001209191-15-045623:0
- 8,700 shares0Common StockSEC:0001209191-15-045623:1
- 194,200 shares0Common StockSEC:0001209191-15-043662:0
- 5,800 shares0Common StockSEC:0001209191-15-043662:1
- 1,852,106 sharesCommon StockSEC:0001209191-14-064608:0
- 55,314 sharesCommon StockSEC:0001209191-14-064608:1
13 of 13 declarations
